GB202208893D0 - Combination therapy for cancer - Google Patents

Combination therapy for cancer

Info

Publication number
GB202208893D0
GB202208893D0 GBGB2208893.4A GB202208893A GB202208893D0 GB 202208893 D0 GB202208893 D0 GB 202208893D0 GB 202208893 A GB202208893 A GB 202208893A GB 202208893 D0 GB202208893 D0 GB 202208893D0
Authority
GB
United Kingdom
Prior art keywords
cancer
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2208893.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medannex Ltd
Original Assignee
Medannex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medannex Ltd filed Critical Medannex Ltd
Priority to GBGB2208893.4A priority Critical patent/GB202208893D0/en
Publication of GB202208893D0 publication Critical patent/GB202208893D0/en
Priority to CA3238416A priority patent/CA3238416A1/en
Priority to AU2022389646A priority patent/AU2022389646A1/en
Priority to EP22821873.1A priority patent/EP4433171A1/en
Priority to PCT/EP2022/082515 priority patent/WO2023089150A1/en
Priority to US18/710,903 priority patent/US20250025553A1/en
Priority to JP2024529689A priority patent/JP2024540569A/en
Priority to TW111144200A priority patent/TW202332698A/en
Priority to CN202280086492.3A priority patent/CN118524851A/en
Priority to KR1020247018081A priority patent/KR20240122606A/en
Ceased legal-status Critical Current

Links

GBGB2208893.4A 2021-11-18 2022-06-16 Combination therapy for cancer Ceased GB202208893D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB2208893.4A GB202208893D0 (en) 2022-06-16 2022-06-16 Combination therapy for cancer
KR1020247018081A KR20240122606A (en) 2021-11-18 2022-11-18 Combination therapy for cancer
PCT/EP2022/082515 WO2023089150A1 (en) 2021-11-18 2022-11-18 Combination therapy for cancer
AU2022389646A AU2022389646A1 (en) 2021-11-18 2022-11-18 Combination therapy for cancer
EP22821873.1A EP4433171A1 (en) 2021-11-18 2022-11-18 Combination therapy for cancer
CA3238416A CA3238416A1 (en) 2021-11-18 2022-11-18 Combination therapy for cancer
US18/710,903 US20250025553A1 (en) 2021-11-18 2022-11-18 Combination therapy for cancer
JP2024529689A JP2024540569A (en) 2021-11-18 2022-11-18 Combination Cancer Therapy
TW111144200A TW202332698A (en) 2021-11-18 2022-11-18 Combination therapy for cancer
CN202280086492.3A CN118524851A (en) 2021-11-18 2022-11-18 Combination therapies for cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2208893.4A GB202208893D0 (en) 2022-06-16 2022-06-16 Combination therapy for cancer

Publications (1)

Publication Number Publication Date
GB202208893D0 true GB202208893D0 (en) 2022-08-10

Family

ID=82705554

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2208893.4A Ceased GB202208893D0 (en) 2021-11-18 2022-06-16 Combination therapy for cancer

Country Status (2)

Country Link
CN (1) CN118524851A (en)
GB (1) GB202208893D0 (en)

Also Published As

Publication number Publication date
CN118524851A (en) 2024-08-20

Similar Documents

Publication Publication Date Title
IL307964A (en) Combination therapy for cancer treatment
PL4225297T3 (en) Combination therapy for treating cancer
IL300171A (en) Combined therapy against cancer
IL304436A (en) Cancer therapy
GB202301902D0 (en) Combination therapy for cancer
GB202208347D0 (en) Targets for cancer therapy
HUE071473T2 (en) Miv-818/lenvatinib combination therapy for liver cancer
GB202218395D0 (en) Cancer therapy
IL321575A (en) Combination therapy for lung cancer
IL316017A (en) Combination therapy for treating cancer
IL316016A (en) Combination therapy for treating cancer
EP4251133C0 (en) Combined therapy against cancer
GB202001963D0 (en) Cancer therapy
GB202208893D0 (en) Combination therapy for cancer
GB202116680D0 (en) Combination therapy for cancer
GB202103673D0 (en) Combination therapy for cancer
GB202318158D0 (en) Cancer therapy
GB202302018D0 (en) Cancer therapy
GB202212918D0 (en) Cancer therapy
GB202508616D0 (en) Combination therapy for cancer
IL317573A (en) Combination therapy for treating cancer
IL316019A (en) Combination therapy for treating cancer
IL305777A (en) Therapeutic combination for treating cancer
CA3243227A1 (en) Combination therapy for cancer
HK40117032A (en) Combination therapy for cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)